StonvexLoading…
StonvexStonvexStonvexCore line items from RVSB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $15.10M | $46.72M | $30.75M | $15.38M | $58.96M |
Operating Income | Not available | $4.68M | $2.94M | $1.55M | $6.24M |
Net Income | Not available | $3.70M | $2.32M | $1.23M | $4.90M |
EPS (Diluted) | $0.07 | $0.18 | $0.11 | $0.06 | $0.23 |
Total Assets | Not available | $1.51B | $1.51B | $1.52B | $1.51B |
Total Liabilities | Not available | $1.35B | $1.35B | $1.35B | $1.35B |
Cash & Equivalents | Not available | $28.64M | $32.81M | $34.17M | $29.41M |
Free Cash Flow OCF − CapEx | Not available | $14.85M | $15.59M | $-773.00K | $5.56M |
Shares Outstanding | Not available | 20.71M | 20.94M | 20.98M | 20.98M |